Top Markets
Coin of the day
Marvel Biosciences Corp. Marvel Biosciences Corp.

Marvel Biosciences Corp.

MRVL
Rank in Stocks #33329
Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical... Marvel Biosciences Corp., a biotechnology company, develops synthetic chemical derivatives of the original approved drug for the new disease indication in Canada. The companyโ€™s lead compound MB-204, a novel fluorinated derivative of istradefylline, an adenosine A2a receptor antagonist to treat alzheimerโ€™s disease and autism spectrum disorder, as well as depression and anxiety. It provides non-hallucinogenic neuroplasticity program. The company is headquartered in Calgary, Canada.
Share Price
$0.12476927
Last synced: 2026-08-14
Market Cap
$7.86M
Change (1 day)
6.25%
Change (1 year)
-19.80%
Country
CA
Trade Marvel Biosciences Corp. (MRVL)

Category

Dividend history for Marvel Biosciences Corp. (MRVL)
Marvel Biosciences Corp. (stock symbol: MRVL) made a total of 0 dividend payments.
The sum of all dividends (adjusted for stock splits) is : 0.00
Dividend yield (TTM) : 0
Dividend payments for Marvel Biosciences Corp. (MRVL) from 2026 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
Not enough data for the provided dates.
List of all dividend payments
Year Dividend Change
Not enough data for the provided dates.
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
NL
0.00%
CH
0.00%
KR
29.00%
BE